Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
Phase of Trial: Phase I/II
Latest Information Update: 10 Oct 2016
Price : $35 *
At a glance
- Drugs Triamcinolone (Primary)
- Indications Uveitis
- Focus Adverse reactions
- Sponsors Clearside Biomedical
- 10 Oct 2016 According to a Clearside Biomedical media release, results from the study will be presented at the Retina Sub-Specialty Day Meeting at the 2016 American Academy of Ophthalmology (AAO) Meeting.
- 03 Aug 2016 According to a Clearside Biomedical media release, combined results from this and a phase II study (Profile 700249389) will be presented at the 2016 Annual Meeting of the American Society of Retina Specialists (ASRS).
- 16 Mar 2015 According to Clearside Biomedical media release, status changed from active, no longer recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History